Next |
home / stock / egrx / egrx message board
Subject | By | Source | When |
---|---|---|---|
Fairly positive investor analysis for $EGRX found at | mcsharkey | investorshub | 03/18/2020 3:47:38 AM |
Eagle Pharmaceuticals to Discuss Fourth Quarter and Full | mcsharkey | investorshub | 02/21/2020 1:41:59 AM |
Good Day Sprycel, | mcsharkey | investorshub | 02/12/2020 2:39:02 AM |
Good Day. Any hope here? With | mcsharkey | investorshub | 02/11/2020 10:36:53 AM |
Well after 2 years they got the FDA | Sprycel | investorshub | 02/22/2019 1:11:51 PM |
They finally did it after 2 years: | Sprycel | investorshub | 02/22/2019 1:10:58 PM |
What is going on with this stock? Just | Denairo | investorshub | 04/03/2018 3:06:02 PM |
Scott Tariff on Biologics acquisition | Bickema | investorshub | 02/26/2018 7:05:24 PM |
http://investor.eagleus.com/press-release/eagle-pharmaceuticals-inc-reports-four | Bickema | investorshub | 02/26/2018 3:10:28 PM |
WIth a market cap of 880 million and | Bickema | investorshub | 02/13/2018 3:20:06 PM |
Have not been here in quite a while, | Denairo | investorshub | 02/12/2018 11:29:52 PM |
Dew how much of the 700 EV for | Bickema | investorshub | 12/11/2017 5:31:33 PM |
big news Only 40 mil market cap cash | make it happen | investorshub | 11/17/2017 4:05:25 PM |
Eagle Pharmaceuticals Announces Positive Results of Study Conducted | Bickema | investorshub | 09/05/2017 6:52:28 PM |
Suing the FDA for Bendeka's Orphan application was | GD | investorshub | 07/27/2017 3:26:53 PM |
Classic Scott Tarriff.... A typical salesman without situational | stugwins | investorshub | 07/27/2017 2:56:24 PM |
$EGRX receives CRL for Ryanodex in heatstroke: #msg-133316969. | DewDiligence | investorshub | 07/26/2017 4:37:18 PM |
Too hot to handle: Study shows Earth's killer | Bickema | investorshub | 06/19/2017 5:45:46 PM |
Class action lawsuit update | bio_fan | investorshub | 05/23/2017 4:39:50 PM |
Replacing a CFO is one of the biggest | W4 | investorshub | 05/17/2017 1:54:07 PM |
News, Short Squeeze, Breakout and More Instantly...
Eagle Pharmaceuticals Inc. Company Name:
EGRX Stock Symbol:
NASDAQ Market:
Eagle Pharmaceuticals Inc. Website:
WOODCLIFF LAKE, N.J., April 30, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that it will deliver a Trial in Progress presentation discussing the ongoing Phase 2/3 study of intravenous amisulpride a...
WOODCLIFF LAKE, N.J., April 15, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that data from the Company’s Phase III trial demonstrating the sustained response of amisulpride for the rescue tr...
WOODCLIFF LAKE, N.J., April 12, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (the “Company”) today announced that it received a notice (the “Notice”) on April 8, 2024 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (...